Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been confirmed to have a solid tumour cancer and have not yet received any treatment for advanced or metastatic (spread) disease.
- People whose cancer is at an advanced stage (Stage III or IV) and where treatment aimed at curing the disease is not considered an option.
- The trial gives preference to women with hormone-positive, HER2-negative breast cancer who will be receiving a specific type of combination hormone therapy; women with any type of lung cancer starting their first treatment; and women with any type of colon cancer starting their first treatment.
- People who are starting treatment as part of another clinical trial may be eligible, as long as the treatments being given are known (not hidden in a double-blind setup).
- People who are generally well enough to carry out daily activities with little to no limitation (this is measured on a medical scale — confirm with trial site).
- People who are able and feel comfortable using a wearable device (such as a smartwatch or fitness tracker).
- People who have a mobile phone with internet access and an email account.
- People who are able to fill in questionnaires about quality of life, nutrition, and mental health.
- People who agree in writing to take part before any study checks begin.
- People with other existing health conditions are not excluded, as the trial is interested in understanding real-world patients.
- Pregnant women are not excluded from this trial.
Who may not be able to join:
- People who have previously received cancer treatment for metastatic or palliative (symptom-managing) disease.
- People who are planning to take part in a double-blind clinical trial for their cancer treatment (where neither the patient nor the doctor knows which treatment is being given).
- People who have, or previously had, another type of cancer that could affect how the study runs or how results are interpreted — although people who have been fully treated for certain early-stage skin cancers or cervical cancer in situ may still be eligible (confirm with trial site).
- People whose other health conditions would significantly interfere with taking part in the trial, as determined by the doctor running the study.
- People who have an implanted electronic medical device such as a pacemaker, defibrillator, or cardiac resynchroniser, due to possible interference with the wearable device used in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Miguel A Quintela, PhD, CNIO- Spanish Research Cancer Center
Phone: +34917328000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Solid cohort of clinical, analytical and epidemiological variables
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.